Literature DB >> 29578161

Incidence of radiation enteritis in cervical cancer patients treated with definitive radiotherapy versus adjuvant radiotherapy.

Yinuo Wang1, Weimin Kong1, Nanan Lv1, Fengshuang Li1, Jiao Chen1, Simeng Jiao1, Ding Ding2, Hui Zhao1, Dan Song1.   

Abstract

OBJECTIVE: The study aimed to evaluate the incidence of early and late radiation enteritis in cervical cancer patients receiving definitive or adjuvant radiotherapy (RT).
MATERIALS AND METHODS: Three hundred and twenty-four cervical cancer patients receiving definite or adjuvant RT in our hospital from January 2010 to December 2012 were divided into definitive (132 patients) or adjuvant RT (192 patients) and performed detailed analysis.
RESULTS: Early radiation enteritis was found in 54.3%, and late radiation enteritis was found in 17.9% of cervical patients. Early (P < 0.007) and late (P < 0.003) radiation enteritis appeared more frequently in patients treated with definitive RT than that with adjuvant RT. In the definitive RT group, incidence of both early and late radiation enteritis in the RT group was higher than in the radiochemotherapy (RCHT) group, and the difference was statistically significant (P < 0.004). Severe cases of late radiation enteritis (Grade 3 and 4) can be seen higher in the definitive radiation group (both the RT and RCHT group) than in the adjuvant radiation group, and the difference was statistically significant (P < 0.005).
CONCLUSION: The incidence of both early and late radiation enteritis in the definitive RT group is higher than in the adjuvant RT group. The occurrence of side effects was associated with the prolongation of total irradiation time due to necessary interruptions of RT. Methods to decrease the interruptions in the RT and the irradiated volume of the small bowel will further lessen enteric morbidity.

Entities:  

Keywords:  Adjuvant radiotherapy; definitive radiotherapy; incidence; radiation enteritis

Mesh:

Year:  2018        PMID: 29578161     DOI: 10.4103/0973-1482.163762

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  6 in total

1.  Identification of differentially expressed genes in cervical cancer by bioinformatics analysis.

Authors:  Yanshan Ge; Chaoyang Zhang; Songshu Xiao; Lin Liang; Shan Liao; Yanqi Xiang; Ke Cao; Hongxiang Chen; Yanhong Zhou
Journal:  Oncol Lett       Date:  2018-06-12       Impact factor: 2.967

2.  Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy.

Authors:  Zhongqiu Wang; Qingxin Wang; Xia Wang; Li Zhu; Jie Chen; Bailin Zhang; Ye Chen; Zhiyong Yuan
Journal:  J Cell Mol Med       Date:  2019-03-25       Impact factor: 5.310

3.  Impact of bladder volume on treatment planning and clinical outcomes of radiotherapy for patients with cervical cancer.

Authors:  Shanshan Ma; Tingting Zhang; Li Jiang; Wen Qin; Keyu Lu; Yong Zhang; Rensheng Wang
Journal:  Cancer Manag Res       Date:  2019-07-29       Impact factor: 3.989

4.  Regulation of the regeneration of intestinal stem cells after irradiation.

Authors:  Liping Liang; Lijun Shen; Guoxiang Fu; Ye Yao; Guichao Li; Yun Deng; Hui Zhang; Menglong Zhou; Wang Yang; Guoqiang Hua; Zhen Zhang
Journal:  Ann Transl Med       Date:  2020-09

5.  Gut Microbiome and Its Associations With Acute and Chronic Gastrointestinal Toxicities in Cancer Patients With Pelvic Radiation Therapy: A Systematic Review.

Authors:  Jinbing Bai; Zahra A Barandouzi; Claire Rowcliffe; Rebecca Meador; Despina Tsementzi; Deborah Watkins Bruner
Journal:  Front Oncol       Date:  2021-12-06       Impact factor: 5.738

6.  Study on Appropriate Rectal Volume for External Irradiation in Patients With Cervical Cancer.

Authors:  Yanjiao Wu; Chunmei Liu; Wenyan Wang; Lei Tian; Zhiqing Xiao; Yanqiang Wang; Han Guo; Xiaoying Xue
Journal:  Front Oncol       Date:  2022-02-22       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.